Pharma Insider Sells 4,772 Shares as 2025 Revenue Hits $883M
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Find criteria to select coins worth holding for 5–10 years, focusing on utility, adoption, and resilience against market cycles.
20,995 articlesA high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
By 2026, European DST policies are still pressing issues for tech giants and online platforms. This guide breaks down...
Beyond Meat (BYND) 2026 unfolds with a mix of top-line growth and cost discipline. This analysis breaks down Q1 resul...
The Stanford board sold HeartFlow shares for about $8.5 million, triggering questions about insider signals. This art...
If you want exposure to the biggest growth names in the U.S., two popular options are MGK and QQQ. This guide breaks ...
With inflation easing and rates hovering, a carefully balanced $200,000 portfolio can generate about $930 a month in ...
A California family filed a wrongful-death lawsuit against OpenAI, claiming ChatGPT guidance led to a teen's fatal ov...
Micron’s latest earnings and bold capex plans intensify the debate over whether the memory giant can achieve a trilli...
When social security disability converts to retirement at full retirement age, beneficiaries keep their current month...
Strategy unveils a private repurchase of roughly $1.5 billion in convertible notes, funded by cash, ATM proceeds, and...
AI stocks have dominated headlines, but long-term winners often come from durable franchises. This article explains w...
Ares Capital has long dazzled income investors with a high dividend yield. After a challenging quarter, the question ...